Cargando…
Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
BACKGROUND: The pharmacokinetics of vancomycin, a drug used for the treatment of methicillin-resistant Staphylococcus aureus (MRSA), varies between paediatric and adult patients. OBJECTIVE: The objective of this study was to assess the pharmacokinetics of vancomycin in preterm neonates and determine...
Autores principales: | Mulubwa, Mwila, Griesel, Heletje Aletta, Mugabo, Pierre, Dippenaar, Ricky, van Wyk, Lizelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221111/ https://www.ncbi.nlm.nih.gov/pubmed/32266599 http://dx.doi.org/10.1007/s40268-020-00302-7 |
Ejemplares similares
-
Amount of Cycloserine Emanating from Terizidone Metabolism and Relationship with Hepatic Function in Patients with Drug-Resistant Tuberculosis
por: Mulubwa, Mwila, et al.
Publicado: (2019) -
Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
por: Akunne, Onyinye Onyeka, et al.
Publicado: (2021) -
Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021) -
Prospective validation of neonatal vancomycin dosing regimens is urgently needed
por: Vandendriessche, Anaïs, et al.
Publicado: (2014) -
Population Pharmacokinetics of Intraventricular Vancomycin in Neonatal Ventriculitis, A Preterm Pilot Study
por: Parasuraman, Jaya Madhura, et al.
Publicado: (2021)